Skip to main content

Table 1 Demographic and clinical characteristics of the study sample at baseline

From: Cost effectiveness of therapist delivered cognitive behavioural therapy and web-based self-management in irritable bowel syndrome: the ACTIB randomised trial

  

TCBT

N = 186

WCBT

N = 185

TAU

N = 187

All

N = 558

Age (years)

Mean (SD)

43·4 (12·5)

43·8 (13·6)

42·0 (13·5)

43·1 (13·2)

Sex

Female (%)

139 (74·7)

145 (78·4)

139 (74·3)

423 (75·8)

Ethnicity (%)

White

162 (87·1)

171 (92·4)

174 (93·0)

507 (90·9)

Deprivation score (IMD 2010)

Mean (SD)

16·7 (12·0)

17·3 (12·3)

17·2 (11·8)

17·1 (12·0)

Seen a GI consultant for IBS

Count (%)

20 (10·7%)

15 (8·1%)

22 (11·8%)

57 (10·2%)

Years of symptoms before diagnosis

N/median

186/3·29

185/3·0

187/3·0

558/ 3·0

Duration of IBS (years)

N/median range

185/6·5

1·0–65·0

185/8·6

0·7–45·4

187/6·3

0·3–49·9

557/7·4

0·3–64·6

HADS anxiety score

Mean (SD)

case* N/(%)

10·6 (4·3)

89/186 (47·9%)

11·1 (4·3)

98/185 (53·0%)

10·5 (4·0)

96/187 (51·3%)

10·7 (4·2)

283/558 (50·7%)

HADS depression Score

Mean (SD)

case* N/(%)

5·5 (3·6)

47/186 (25·3%)

5·9 (3·8)

60/185 (32·4%)

5·6 (3·5)

50/187 (26·7%)

5·7 (3·7)

157/558 (28·1%)

IBS subtype IBS Diarrhoea

No. (%)

60 (32.3)

60 (32.4)

58 (31.0)

178 (31.9)

IBS constipation

No. (%)

26 (14.0)

23 (12.4)

27 (14.5)

76 (13.6)

IBS alternating

No. (%)

93 (50.3)

98 (53.0)

96 (51.3)

287 (51.5)

IBS unclassified

No. (%)

6 (3.2)

4 (2.2)

6 (3.2)

16 (2.9)

Unknown

No. (%)

60 (32.3)

60 (32.4)

58 (31.0)

178 (31.9)

  1. *HADS case of anxiety defined as scoring \(\geqq \) 10/21 and depression as scoring \(\geqq \) 7/21 on subscale